Article
Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
Genes, chromosomes & cancer - 1 Sept 2010
Schmidt Annette, Schmitz Roland, Giefing Maciej, Martin-Subero Jose Ignacio, Gesk Stefan, Vater Inga, Massow Anne, Maggio Ewerton, Schneider Markus, Hansmann Martin-Leo, Siebert Reiner, Küppers Ralf
Abstract excerpt
Survival of the malignant Hodgkin and Reed/Sternberg (HRS) cells in classical Hodgkin lymphoma (cHL) is dependent on constitutive activation of the nuclear factor kappaB (NF-kappaB) transcription factor. The deubiquitinating enzyme CYLD is a negative regulator of NF-kappaB and known to function as a tumor suppressor. To determine whether CYLD mutations play a role in cHL pathogenesis, we sequenced the gene in cHL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
